Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Cascione · SciRah

Researcher profile · Semantic Scholar

L. Cascione

Share profile

L. Cascione — researcher profile on SciRah

h-index: 40
Works: 269
Citations: 5,853

Most-cited papers

SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model.
L. Ceriani, G. Gritti, L. Cascione, M. Pirosa +13 more
2020Blood Advances67 citations Open access
Semantic Scholar
Retraction Note: EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
M. Garofalo, G. Romano, G. di Leva, G. Nuovo +13 more
2022Nature Medicine50 citations Open access
Semantic Scholar
Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas.
M. Barreca, V. Spanò, R. Rocca, R. Bivacqua +15 more
2022European journal of medicinal chemistry38 citations Open access
Semantic Scholar
Circulating microRNA analysis in a prospective co-clinical trial identifies MIR652-3p as a response biomarker and driver of regorafenib resistance mechanisms in colorectal cancer.
S. Hedayat, L. Cascione, D. Cunningham, M. Schirripa +42 more
2024Clinical Cancer Research33 citations
Semantic Scholar
Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models.
C. Tarantelli, M. Lange, E. Gaudio, L. Cascione +17 more
2020Blood Advances31 citations Open access
Semantic Scholar
IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance
Z. Johnson, C. Tarantelli, E. Civanelli, L. Cascione +14 more
2023Cancer Research Communications29 citations Open access
Semantic Scholar
Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma
J. Alderuccio, I. Reis, T. Habermann, B. Link +8 more
2022American journal of hematology/oncology28 citations Open access
Semantic Scholar
Specified
M. Laginestra, L. Cascione, G. Motta, F. Fuligni +15 more
2020Definitions28 citations Open access
Semantic Scholar
RNAdetector: a free user-friendly stand-alone and cloud-based system for RNA-Seq data analysis
A. La Ferlita, S. Alaimo, S. Di Bella, Emanuele Martorana +7 more
2021BMC Bioinformatics24 citations Open access
Semantic Scholar
Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors.
A. Mensah, F. Spriano, G. Sartori, V. Priebe +12 more
2021Blood Advances23 citations Open access
Semantic Scholar
Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis
A. Arribas, Sara Napoli, L. Cascione, G. Sartori +21 more
2022Haematologica20 citations Open access
Semantic Scholar
MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer
A. Lampis, J. Hahne, Pierluigi Gasparini, L. Cascione +14 more
2021Cell Death and Differentiation20 citations Open access
Semantic Scholar
Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R‐CHOP14: A SAKK 38/07 trial post‐hoc analysis
L. Ceriani, L. Milan, L. Cascione, G. Gritti +12 more
2021Hematological Oncology20 citations
Semantic Scholar
Prognostic models integrating quantitative parameters from baseline and interim positron emission computed tomography in patients with diffuse large B‐cell lymphoma: post‐hoc analysis from the SAKK38/07 clinical trial
E. Zucca, L. Cascione, T. Ruberto, D. Facchinelli +7 more
2020Hematological Oncology19 citations
Semantic Scholar
The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib
G. Sartori, C. Tarantelli, F. Spriano, E. Gaudio +14 more
2023bioRxiv17 citations Open access
Semantic Scholar
Targeting CD19-positive lymphomas with the antibody-drug conjugate loncastuximab tesirine: preclinical evidence of activity as a single agent and in combination therapy
C. Tarantelli, David Wald, N. Munz, F. Spriano +17 more
2024Haematologica16 citations Open access
Semantic Scholar
Subcapsular Sinus Macrophages Promote Melanoma Metastasis to the Sentinel Lymph Nodes via an IL1α–STAT3 Axis
T. Virgilio, Joy Bordini, L. Cascione, G. Sartori +21 more
2022Cancer immunology research16 citations Open access
Semantic Scholar
DNA Copy Number Changes in Diffuse Large B Cell Lymphomas
L. Cascione, L. Aresu, M. Baudis, F. Bertoni
2020Frontiers in Oncology16 citations Open access
Semantic Scholar
In situ hybridization to detect DNA amplification in extracellular vesicles
L. Casadei, Patricia Sarchet, F. C. D. de Faria, Federica Calore +8 more
2022Journal of Extracellular Vesicles14 citations Open access
Semantic Scholar
Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling
F. Galuppini, S. Censi, Isabella Merante Boschin, M. Fassan +13 more
2022Frontiers in Endocrinology12 citations Open access
Semantic Scholar
KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells
R. Frazzi, Vincenza Ylenia Cusenza, M. Pistoni, Laura Canovi +3 more
2021Oncology Report12 citations Open access
Semantic Scholar
ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma
G. Sartori, Sara Napoli, L. Cascione, E. Y. Chung +11 more
2021Journal of experimental & clinical cancer research : CR12 citations Open access
Semantic Scholar
A DNA biosensors-based microfluidic platform for attomolar real-time detection of unamplified SARS-CoV-2 virus
P. Robin, L. Barnabei, S. Marocco, Jacopo Pagnoncelli +11 more
2022Biosensors and Bioelectronics: X11 citations Open access
Semantic Scholar
Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study
S. Genta, G. Ghilardi, L. Cascione, D. Juskevicius +12 more
2022Cancers11 citations Open access
Semantic Scholar
ADCT-602, a Novel PBD Dimer–containing Antibody–Drug Conjugate for Treating CD22-positive Hematologic Malignancies
F. Zammarchi, K. Havenith, N. Sachini, N. Janghra +14 more
2024Molecular Cancer Therapeutics10 citations Open access
Semantic Scholar
ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms.
A. Arribas, Sara Napoli, L. Cascione, L. Barnabei +20 more
2023Molecular Cancer Therapeutics10 citations Open access
Semantic Scholar
Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type
V. Priebe, G. Sartori, Sara Napoli, E. Y. Chung +12 more
2020Cancers8 citations Open access
Semantic Scholar
PET-Based Risk Stratification in Primary Mediastinal B-Cell Lymphoma: A Comparative Analysis of Different Segmentation Methods in the IELSG37 Trial Patient Cohort
L. Ceriani, L. Milan, M. Pirosa, Maurizio Martelli +6 more
2025Journal of Nuclear Medicine7 citations Open access
Semantic Scholar
Extracellular vesicle - MDM2-DNA as a potential liquid biopsy biomarker for disease identification in retroperitoneal liposarcoma
Federica Calore, L. Casadei, Patricia D. Sarchet, P. Fadda +8 more
2024Annals of Surgery7 citations Open access
Semantic Scholar
PI3Kδ activation, IL-6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas
A. Arribas, Sara Napoli, E. Gaudio, C. Herbaux +17 more
2024Blood Advances6 citations Open access
Semantic Scholar
The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like type
C. Tarantelli, Eleonora Cannas, H. Ekeh, Carmelo Moscatello +11 more
2021Exploration of Targeted Anti-tumor Therapy6 citations Open access
Semantic Scholar
A first-in-class Wiskott-Aldrich syndrome protein activator with antitumor activity in hematologic cancers
F. Spriano, G. Sartori, Jacopo Sgrignani, L. Barnabei +39 more
2024Haematologica5 citations Open access
Semantic Scholar
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
L. Ceriani, L. Milan, L. Cascione, A. Di Rocco +7 more
2023Hematological Oncology5 citations
Semantic Scholar
ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells
E. Y. Chung, G. Sartori, M. Ponzoni, L. Cascione +15 more
2023British Journal of Haematology4 citations Open access
Semantic Scholar
In vitro anti‐lymphoma activity of the first‐in‐class pan‐NOTCH transcription inhibitor CB‐103
F. Spriano, C. Tarantelli, A. Arribas, E. Gaudio +10 more
2022British Journal of Haematology4 citations Open access
Semantic Scholar
Exon–Intron Differential Analysis Reveals the Role of Competing Endogenous RNAs in Post-Transcriptional Regulation of Translation
N. Munz, L. Cascione, Luca Parmigiani, C. Tarantelli +6 more
2021Non-Coding RNA4 citations Open access
Semantic Scholar
Understanding the mechanism of action of pyrrolo[3,2-b]quinoxaline-derivatives as kinase inhibitors
A. Unzue, C. Jessen-Trefzer, D. Spiliotopoulos, E. Gaudio +12 more
2020RSC Medicinal Chemistry4 citations Open access
Semantic Scholar
Targeting of PIM Kinases Shows Single Agent Efficacy and Synergizes With BCL2 Inhibitors in Diffuse Large B Cell Lymphoma of the ABC Subtype
C. Tarantelli, Omar Kayali, E. Civanelli, L. Cascione +7 more
2025Hematological Oncology3 citations Open access
Semantic Scholar
Targeting CD25+ lymphoma cells with the antibody–drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agents
F. Spriano, C. Tarantelli, L. Cascione, E. Gaudio +9 more
2024British Journal of Haematology3 citations Open access
Semantic Scholar
ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms
A. Arribas, Sara Napoli, L. Cascione, L. Barnabei +20 more
2023bioRxiv3 citations Open access
Semantic Scholar
PI3Kδ activation, IL6 over-expression, and CD37 loss cause resistance to the targeting of CD37-positive lymphomas with the antibody-drug conjugate naratuximab emtansine
A. Arribas, E. Gaudio, Sara Napoli, Charles Jean Yvon Herbaux +16 more
2023bioRxiv3 citations Open access
Semantic Scholar
Abstract PO-46: Mechanisms of resistance to the PI3K inhibitor copanlisib in marginal zone lymphoma
A. Arribas, Sara Napoli, L. Cascione, E. Gaudio +11 more
20203 citations
Semantic Scholar
MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcoma
M. Sapienza, F. Fuligni, F. Melle, V. Tabanelli +16 more
2020Hematological Oncology3 citations
Semantic Scholar
PET-Based Prognostic Stratification in Primary Mediastinal B-Cell Lymphoma Using the SUV≥4 Segmentation Threshold: A Comparative Analysis of Contouring Methods in the IELSG37 Trial Cohort
L. Ceriani, L. Milan, M. Pirosa, A. Di Rocco +6 more
2024Blood2 citations
Semantic Scholar
Comprehensive Analysis of 177Lu-lilotomab Satetraxetan in Lymphoma Cell Lines: Implications for Precision Radioimmunotherapy and Combination Schemes
S. Patzke, L. Cascione, K. Melhus, N. Munz +6 more
2024bioRxiv2 citations Open access
Semantic Scholar
Characterization of a novel humanized heavy chain antibody targeting endogenous retroviruses with anti-lymphoma activity
F. Spriano, L. Cascione, Jacopo Sgrignani, N. Bendik +10 more
2024bioRxiv2 citations Open access
Semantic Scholar
Targeting CD25-positive lymphoma cells with the antibody-drug conjugate camidanlumab tesirine as single agent or in combination with targeted agents
F. Spriano, C. Tarantelli, L. Cascione, E. Gaudio +7 more
2023bioRxiv2 citations Open access
Semantic Scholar
Targeting CD19-positive lymphomas with the antibody-drug conjugate (ADC) loncastuximab tesirine: preclinical evidence as single agent and as combinatorial approach
C. Tarantelli, D. Wald, N. Munz, F. Spriano +15 more
2023bioRxiv2 citations Open access
Semantic Scholar
The microtubule-targeted agent lisavanbulin (BAL101553) shows anti-tumor activity in lymphoma models.
F. Spriano, L. Aresu, L. Cascione, Giorgia Risi +7 more
2023American Journal of Cancer Research2 citations
Semantic Scholar
Stable CDK12 Knock-Out Ovarian Cancer Cells Do Not Show Increased Sensitivity to Cisplatin and PARP Inhibitor Treatment
Rosaria Chilà, M. Chiappa, F. Guffanti, N. Panini +6 more
2022Frontiers in Oncology2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Bertoni×24
Invite
F. Bertoni — researcher profile on SciRah
E. Zucca×23
Invite
E. Zucca — researcher profile on SciRah
C. Tarantelli×23
Invite
C. Tarantelli — researcher profile on SciRah
A. Arribas×19
Invite
A. Arribas — researcher profile on SciRah

×18

Invite

A. Stathis — researcher profile on SciRah

Invite

A. Rinaldi — researcher profile on SciRah

Invite

F. Spriano — researcher profile on SciRah

Sara Napoli×13

Invite

Sara Napoli — researcher profile on SciRah

Invite

G. Sartori — researcher profile on SciRah

Invite

E. Gaudio — researcher profile on SciRah

Invite

E. Gaudio — researcher profile on SciRah

Invite

D. Rossi — researcher profile on SciRah